Boston Scientific pours more money into Ireland, this time for Stryker | On Call

October 14, 2011 by MassDevice staff

Boston Scientific seeks permission to add a $41 million manufacturing facility to its Irish campus to house the neurovascular unit that Stryker purchased earlier this year.

MassDevice On Call

MASSDEVICE ON CALL —Boston Scientific Corp. (NYSE:BSX) began seeking approval for a $41 building project in Ireland to house the neurovascular unit it sold to Stryker Corp. (NYSE:SYK) earlier this year.

The 100,000 square foot facility will live on Boston Scientific's Cork, Ireland, campus but will be operated by Stryker, and some 600 local BSX employees will transfer to the new facility when it's ready.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.